New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 26, 2014
06:37 EDTBLUEbluebird bio price target raised to $58 from $51 at Piper Jaffray
Piper Jaffray raised its price target for bluebird bio (BLUE) shares to $58 saying the beta thal market provides opportunity for both bluebird and Biogen (BIIB). Piper sees a possible market split should both companies' data remain positive. It keeps an Overweight rating on bluebird bio.
News For BLUE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 17, 2014
11:49 EDTBLUEPiper Jaffray healthcare analysts to hold an analyst/industry conference call
Subscribe for More Information
07:16 EDTBLUEMilken Institute--Faster Cures to hold a conference
Subscribe for More Information
November 13, 2014
07:30 EDTBLUECredit Suisse to hold a conference
Healthcare Conference is being held in Scottsdale, Arizona on November 10-13 with webcasted company presentations to begin on November 13 at 11 am; not all company presentations may be webcasted. Webcast Link
November 12, 2014
07:08 EDTBLUEbluebird bio reports Q3 EPS (61c), consensus (50c)
Reports Q3 revenue $6.37M, consensus $6.21M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use